Navigation Links
Rapamycin: Limited anti-aging effects
Date:7/25/2013

er's summary of the findings. "Most aging traits were not affected by rapamycin treatment. Although we did observe positive effects on some aging traits, such as memory impairments and reduced red blood cell counts, our studies showed that similar drug effects are also seen in young mice, indicating that rapamycin did not influence these measures by slowing aging, but rather via other, aging-independent, mechanisms."

The researchers believe that such aging-independent drug effects also underlie rapamycin's effect on lifespan. "We assume that the lifespan of mice is extended because rapamycin inhibits tumor formation. This is a well-known rapamycin effect, which we were able to confirm. Cancer is the leading cause of death in the relevant mouse strains" says the specialist in molecular medicine. "Rapamycin, therefore, seems to have isolated effects on specific life-limiting pathology, but lacks broad effects on aging in mice."

A comprehensive assessment of aging

The research team assessed more than 150 traits, which typically change during the course of aging. These analyses included an assessment of vision, reflexes, cardiovascular function, learning and behavior, immune functions and the integrity of the arterial wall, to just name a few. "Aging is a complex process, which cannot be captured by assessing a single parameter. This is why we analysed a large number of structural and functional signs of aging," explains Ehninger. "The present study is one of the most comprehensive assessments of a putative anti-aging intervention."

The analysis comprised three different age cohorts, in which rapamycin treatment was either initiated in young adulthood, in midlife or late in life. "At the time, the US study showed that rapamycin extends lifespan irrespective of whether the treatment is given to young or aged animals," says the Bonn-based researcher. "We, therefore, chose a study design, in the context of which we also investiga
'/>"/>

Contact: Dr. Dirk Förger
presse@dzne.de
49-228-433-02260
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Oysters could rebound more quickly with limited fishing and improved habitat
2. Older US-born Mexican-Americans more physically limited than Mexican-American immigrants: Study
3. Most coral reefs are at risk unless climate change is drastically limited
4. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
5. Scientists sequence genome of sacred lotus, which likely holds anti-aging secrets
6. Hydrogen sulfide: The next anti-aging agent?
7. Anti-aging elixir for solar cells
8. Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles
9. Key target responsible for triggering detrimental effects in brain trauma identified
10. Adverse effects of phthalates on ovarian response to IVF
11. Time is of the essence for reducing the long-term effects of iron deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2015)... 10, 2015 Transforming How We ... "Personalized Medicine in Human Space Flight" by ... Goodwin , Ph.D. was recently featured by Springer Science ... years. Specifically, "Personalized Medicine in Human Space ... published in 2013 and 2014 from Springer in the ...
(Date:3/5/2015)... SAO PAULO , March 5, 2015 In ... with 41 percent of companies already using these solutions and ... of 2015. Of the latter, approximately 25 percent of the ... time. While the majority of companies in the ... is anticipated that the hybrid model will command significant attention ...
(Date:3/2/2015)... March 2, 2015 Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new implementation ... to enable rapid and secure transactions and reliable ... gaming is a turnkey solution providing mouse and ... quickly integrate fingerprint ID solutions into their product ...
Breaking Biology News(10 mins):"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
... risk of acquiring HIV rises during pregnancy, according to ... by researchers at the Johns Hopkins Bloomberg School of ... even after researchers controlled for behavior and other factors ... published in the September 30, 2005, edition of The ...
... trial, a new drug that selectively blocks immune ... kidney transplant rejection as cyclosporine, the standard anti-rejection ... drug, a co-stimulatory blocker called belatacept (LEA29Y), also ... the toxic side effects associated with standard anti-rejection ...
... have tracked down the biological trigger that gives ... bone disorder that can cause blindness and deafness. ... and could lead to new treatments for osteoporosis ... team from Lawrence Livermore and Lawrence Berkeley national ...
Cached Biology News:Pregnant women at higher risk for HIV, Uganda study finds 2New type of rejection blocker protects kidneys after transplant 2New type of rejection blocker protects kidneys after transplant 3New type of rejection blocker protects kidneys after transplant 4Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/27/2015)... RI (PRWEB) March 27, 2015 Earlier ... for the promotion of hair regrowth in adult men ... classifications I-II or Norwood Hamilton classifications of IIa-V and ... an industry plagued by products that over-promise and under-deliver, ... Capillus272Pro™, renewing faith and confidence among more than 80 ...
(Date:3/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... in accordance with Securities and Exchange Commission rule 10b5-1. ... Corporation, is a minority owner of this entity that ... Herbert does not have control of this entity, but ... for a portion of the shares owned by that ...
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2Neogen CEO adopts 10b5-1 Trading Plan 2
... Leonhardt,s Launchpads ( www.leonhardtslaunchpads.com ), at the ... Center ( www.uncm.edu/STIC.php ), 2330 Circadian Way, Santa ... Grand Opening on Tuesday, November 9th from 3pm ... incubator for startup businesses and high-potential entrepreneurs in ...
... Inc. Prices $50 Million Public Offering ... ... lpUnit=,PRN,; --> ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... Davis Phinney Foundation ( http://www.davisphinneyfoundation.org ), a non-profit foundation ... help people to live well with Parkinson,s disease, today ... Exercise and Parkinson,s: Questions and Answers from the Experts ... experts in the fields of physical therapy and exercise ...
Cached Biology Technology:OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 2OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 3OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 4OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 5OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 6OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 8OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 9Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 2Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 3Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinson's Disease 4
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
TXNL2 Antibody...
Biology Products: